Skip to main content

Table 1 Baseline characteristics of the study population

From: Relation between regional and global systolic function in patients with ischemic cardiomyopathy after β-Blocker therapy or revascularization

  β-Blocker therapy Revascularization
  (n = 20) (n = 12)
Age (yrs) 67 ± 8 68 ± 6
Gender (male/female) 20/0 11/1
Time to follow-up (months) 8 ± 3 9 ± 4
Nr of stenosed (> 70%) coronary arteries 2.7 ± 0.5 2.5 ± 0.5
Nr of segments with contractile reserve 5.5 ± 3.2 3.7 ± 1.7
NYHA classification 2.3 ± 0.5 2.2 ± 0.5
Medication:
Asperin 95% 100%
Angiotensin converting enzyme inhibitors 65% 58%
Diuretics 55% 50%
Nitrates 35% 50%
Nr of segments with:
Dysfunctional tissue 7.4 ± 3.2 5.5 ± 1.5
Adjacent tissue 6.3 ± 2.0 6.5 ± 1.1
Remote tissue 3.4 ± 2.6 5.1 ± 2.0
  1. All comparisons between both groups were statistically non-significant.